The theme of this program project is to define and quantitate the effects of certain cigarette smoke constituents, some of which are broadly distributed in nature in other plant products, on the immune system broadly defined to include humoral and cellular immunity (Projects I, III, and V), coagulation pathways (Projects I and II), the complement system (Projects II and IV), and how these, acting individually or in concert, may contribute to arteriosclerosis (Projects I and III), thrombosis and ischemic injury (Project II) and cardiac arrhythmia and sudden death (Project V). We also propose to determine if the effects of cigarette smoking on these pathways contributes to the pathogenesis of utero-placental injury and are the basis of the association between cigarette smoking and perinatal morbidity and mortality (Project II). Through the studies proposed we hope to gain a better understanding of the multiple mechanisms by which cigarette smoking can perturb the immune system. This may provide insight into its association with cardiovascular, pulmonary, and perinatal disease, insight into the nature of other unidentified exogenous risk factors in the diet or the work place which might work through similar immunopathologic mechanisms, and a mechanistic and clinically measurable definition of those individuals who are at risk. Titles of component research projects are as follows: Project I - Anti-idiotypic Responses and Cardiovascular Disease. Project II - Experimental Cardiac and Uteroplacental Injury in Rabbits. Project III - Immunobiology of Tobacco and Related Plant Products. Project IV - Tobacco, Plant Products and the Complement System. Project V - Cardiovascular and Pulmonary Immune Responses to Tobacco.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL037407-03
Application #
3098564
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1986-12-01
Project End
1991-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Santos-Buch, C A; Hall, H R; Farfan, F et al. (1995) Characterization of the tobacco glycoprotein surface binding property of heart and skeletal muscle cells. I. Modulation of the heart cell membrane TGP interaction by anti-TGP IgG. Arch Toxicol 69:149-59
Francus, T (1994) Plant polyphenolic-protein conjugates activate murine spleen cells and bind to multiple cell surface components. Proc Soc Exp Biol Med 207:117-26
Francus, T; Romano, P M; Manzo, G et al. (1992) IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol 145:156-74
Francus, T; Francus, Y; Siskind, G W (1991) Memory T cells enhance the expression of high-avidity naive B cells. Cell Immunol 134:520-7
Baum, C G; Szabo, P; Siskind, G W et al. (1990) Cellular control of IgE induction by a polyphenol-rich compound. Preferential activation of Th2 cells. J Immunol 145:779-84
Francus, T; Manzo, G; Canki, M et al. (1989) Two peaks of interleukin 1 expression in human leukocytes cultured with tobacco glycoprotein. J Exp Med 170:327-32
Stuehr, D J; Kwon, N S; Gross, S S et al. (1989) Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components. Biochem Biophys Res Commun 161:420-6
Rothermel, C D; Schachter, J; Lavrich, P et al. (1989) Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun 57:2705-11
Sakuma, I; Gross, S S; Levi, R (1989) Positive inotropic effect of the thromboxane analog U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover. Can J Physiol Pharmacol 67:943-9
del Balzo, U; Polley, M J; Levi, R (1989) C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated. J Pharmacol Exp Ther 248:1003-9

Showing the most recent 10 out of 25 publications